Buy, sell, repeat–I’m not buying on the dip yet–but I am making a few quick trades to take advantage of the volatility; my trade today in AMAT is an example

Buy, sell, repeat–I’m not buying on the dip yet–but I am making a few quick trades to take advantage of the volatility; my trade today in AMAT is an example

I’m very reluctant to go bottom fishing here–since I can’t tell where the bottom might be and the one-day losses are significant here. Tesla (TSLA), for example, was down 8.06% TODAY. That’s $59.80 dollars a share. Teladoc (TDOC) dropped 13.74% or $34.98 a share. Guessing wrong on a bottom could be very expensive here. But I am willing to try a few trades. Nothing fancy. Very short-term. But using stocks with very strong longer-term stories that make me feel good about the longer-term prospects for the stocks. And to believe that there are significant numbers of potential bargain hunters hiding in the bushes. So, for example, I’ve been trading in and out of the Call Options on Applied Materials (AMAT).

Vaxart is looking like a “short-squeeze rocket”–is it?

Vaxart is looking like a “short-squeeze rocket”–is it?

Ok, I don’t want to see “the next GameStop under every rock.” But Vaxart (VXRT) deserves a look or two. (The stock is a member of my Volatility Portfolio where it’s up 5.27 as of the close on February 1 since I added it to the portfolio on July 22, 2020. I also own shares in my personal portfolio.) Here’s what I see with the shares of this company that is in clinical trials of a vaccine for the coronavirus. Vaxart’s vaccine is a pill and it’s the only vaccine pill under development. Shares of Vaxart are up (as of the February 1 close) 54.93% in the last week and 172.68% in the last month. They’ve added 216.46% in the last 3 months and are up 172.68% for 2021 to date as of the close on February 1. The shares moved up another 29.97% today to $15.57 a share.

Accepting what we don’t know (what no one knows) about prices in this market

Accepting what we don’t know (what no one knows) about prices in this market

I looked at my Jubak Picks Portfolio with more than a tinge of seller’s remorse this morning. I sold shares of First Majestic Silver (AG) out of that portfolio on Friday, January 29, after the stock rose 21.38% on Thursday. That gave me a gain of 45.52% since I began this position on July 6, 2019.I argued in justification for this sell that the attempt by individual investors on Reddit’s WallStreetBets forum to force a short squeeze in silver, as they had in GameStop (GME), were likely to fail because there was such a big stockpile of physical silver ready to enter the market. So I took my profit. Only to have the stock climb an other 21.3% today, February 1, as of 2:30 p.m. New York time as individual investors did indeed drive up the price of silver futures. The Shares Silver Trust (SLV) was up 6.40% as of 2:30 New York time today as the intraday price of silver limbed to the highest level since 2013. And then I thought about that seller’s remorse.

Buying MGM Puts on today’s bounce: Prologue to my Special Report My Special Report “Your Investing Guide for the Next Six Dangerous Stock Market Months” with 10 investment moves for a crazy, crazy market.

Buying MGM Puts on today’s bounce: Prologue to my Special Report My Special Report “Your Investing Guide for the Next Six Dangerous Stock Market Months” with 10 investment moves for a crazy, crazy market.

I'm not waiting until I post all of my newest Special Report: "Your Investing Guide for the Next Six Dangerous Stock Market Months with 10 investment moves for a crazy, crazy market" to make this buy on the MGM Resorts International (MGM) Puts with a strike price of...
Part 3 in my series on the Vaccine Put–how you can protect your portfolio if this support for stock prices falters over the next two or three months

Part 3 in my series on the Vaccine Put–how you can protect your portfolio if this support for stock prices falters over the next two or three months

Just in case you needed an example of how powerful the Vaccine Put is, check out today's (September 14) action in the U.S. stocks. On positive "indications" about a possible coronavirus treatment, Incyte (INCY) was up 5.55% as of 3 p.m. New York time. On positive news...